Why Teva's Stock Could Crash Another 50% Post author:Sam Post published:November 7, 2017 Post category:BioPharma Teva continues to be battered by its massive debt load and struggling pipeline. Source: BioSpace You Might Also Like AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints July 26, 2017 PPD???s Recognized For Industry Leadership August 10, 2017 Bay Area's Global Blood Therapeutics Terminates Lung Disease Program October 22, 2017
